• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Norditropin Cartridges (somatropin [rDNA origin] injection)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – May 2011

 

Summary View

WARNINGS AND PRECAUTIONS

Impaired Glucose Tolerance and Diabetes Mellitus
  • ...New-onset Type 2 diabetes mellitus has been reported.

Pancreatitis
  • Cases of have been reported rarely in children and adults receiving somatropin treatment, with some evidence supporting a greater risk in children compared with adults. Published literature indicates that girls who have Turner syndrome may be at greater risk than other somatropin-treated children. Pancreatitis should be considered in any somatropin–treated patient, especially a child, who develops persistent severe abdominal pain.


ADVERSE REACTIONS

Postmarketing Experience
  • New-onset Type 2 diabetes mellitus has been reported